Skip to main content
Log in

Desired Qualities of Endovascular Tools and Barriers to Treating Medium Vessel Occlusion MeVO

Insights from the MeVO-FRONTIERS International Survey

  • Original Article
  • Published:
Clinical Neuroradiology Aims and scope Submit manuscript

Abstract

Background

Endovascular treatment (EVT) for stroke due to medium vessel occlusion (MeVO) can be technically challenging and specific endovascular tools are needed to safely and effectively recanalize these relatively small and fragile vessels. We aimed to gain insight into availability and desired qualities of endovascular devices used in MeVO stroke and examined barriers to adoption of MeVO EVT in clinical practice on a global scale.

Methods

We conducted a case-based international survey among neurointerventionalists. As a part of the survey, participants were asked whether they felt appropriate endovascular tools for MeVO stroke exist and are available to them in their clinical practice. We then examined barriers to adopting MeVO EVT and analyzed them by geographic regions.

Results

A total of 263 neurointerventionists participated, of which 178 (67.7%) and 83 (31.6%) provided responses on desired qualities of MeVO EVT tools and on barriers to their adoption in local practice, respectively. The majority 121/178 (68%) felt there was substantial room for improvement regarding existing tools. A large proportion 131/178 (73.6%) felt they had appropriate access to existing tools. The most commonly mentioned barrier for adopting MeVO EVT in North America was “awaiting better tools” (9/28 responses, 32.1%), while “awaiting better evidence” (8/26 responses, 30.8%), and the need for improved “funding” (7/26 responses, 26.9%) were important barriers in Europe.

Conclusion

The majority of surveyed neurointerventionalists felt that dedicated MeVO EVT tools can be substantially improved upon. Different regions face various challenges in adoption of MeVO EVT, but overall, physicians are mostly awaiting better MeVO EVT tools.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Ospel JM, Menon BK, Demchuk AM, Almekhlafi MA, Kashani N, Mayank A, Fainardi E, Rubiera M, Khaw A, Shankar JJ, Dowlatshahi D, Puig J, Sohn SI, Ahn SH, Poppe A, Calleja A, Hill MD, Goyal M. Clinical Course of Acute Ischemic Stroke Due to Medium Vessel Occlusion With and Without Intravenous Alteplase Treatment. Stroke. 2020;51:3232–40.

    Article  CAS  PubMed  Google Scholar 

  2. Saver JL, Chapot R, Agid R, Hassan A, Jadhav AP, Liebeskind DS, Lobotesis K, Meila D, Meyer L, Raphaeli G, Gupta R; Distal Thrombectomy Summit Group*†. Thrombectomy for Distal, Medium Vessel Occlusions: A Consensus Statement on Present Knowledge and Promising Directions. Stroke. 2020;51:2872–84. Erratum in: Stroke. 2020;51:e296.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Elhorany M, Rosso C, Shotar E, Baronnet-Chauvet F, Premat K, Lenck S, Crozier S, Corcy C, Bottin L, Mansour OY, Talbi A, El-Din EAT, Fadel WA, Sourour NA, Alamowitch S, Samson Y, Clarençon F. Safety and effectiveness of mechanical thrombectomy for primary isolated distal vessel occlusions: A monocentric retrospective comparative study. J Neuroradiol. 2022;49:311–6.

    Article  PubMed  Google Scholar 

  4. Renieri L, Valente I, Dmytriw AA, Puri AS, Singh J, Nappini S, Nencini P, Kaliaev A, Abdalkader M, Alexandre A, Garignano G, Vivekanandan S, Fong RP, Parra-Fariñas C, Spears J, Gomez-Paz S, Ogilvy C, Regenhardt RW, Alotaibi N, Beer-Furlan A, Joshi KC, Walker M, Vicenty-Padilla J, Darcourt J, Foreman P, Kuhn AL, Nguyen TN, Griessenauer CJ, Marotta TR, Thomas A, Patel AB, Leslie-Mazwi TM, Chen M, Levitt MR, Chen K, Cognard C, Pedicelli A, Limbucci N. Mechanical thrombectomy beyond the circle of Willis: efficacy and safety of different techniques for M2 occlusions. J Neurointerv Surg. 2022;14:546–50.

    Article  Google Scholar 

  5. Kashani N, Cimflova P, Ospel JM, Singh N, Almekhlafi MA, Rempel J, Fiehler J, Chen M, Sakai N, Agid R, Heran M, Kappelhof M, Goyal M. Endovascular Device Choice and Tools for Recanalization of Medium Vessel Occlusions: Insights From the MeVO FRONTIERS International Survey. Front Neurol. 2021;12:735899.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Gupta R, Saver JL, Levy E, Zaidat OO, Yavagal D, Liebeskind DS, Khaldi A, Gross B, Lang M, Narayanan S, Jankowitz B, Snyder K, Siddiqui A, Davies J, Lin E, Hassan A, Hanel R, Aghaebrahim A, Kaushal R, Malek A, Mueller-Kronast N, Starke R, Bozorgchami H, Nesbit G, Horikawa M, Priest R, Liu J, Budzik RF, Pema P, Vora N, Taqi MA, Samaniego E, Wang QT, Nossek E, Dabus G, Linfante I, Puri A, Abergel E, Starkman S, Tateshima S, Jadhav AP; TIGER Trial Investigators. New Class of Radially Adjustable Stentrievers for Acute Ischemic Stroke: Primary Results of the Multicenter TIGER Trial. Stroke. 2021;52:1534–44. Erratum in: Stroke. 2021;52:e310.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Pérez-García C, Rosati S, Gómez-Escalonilla C, López-Frías A, Arrazola J, Moreu M. MeVO SAVE technique: initial experience with the 167 cm long NeuroSlider 17 for a combined approach in medium vessel occlusions (MeVOs). J Neurointerv Surg. 2021;13:768.

    Article  PubMed  Google Scholar 

  8. Navia P, Larrea JA, Pardo E, Arce A, Martínez-Zabaleta M, Díez-González N, Murias E, Arráez-Aybar LA, Massó J. Initial experience using the 3MAX cerebral reperfusion catheter in the endovascular treatment of acute ischemic stroke of distal arteries. J Neurointerv Surg. 2016;8:787–90.

    Article  PubMed  Google Scholar 

  9. Altenbernd J, Kuhnt O, Hennigs S, Hilker R, Loehr C. Frontline ADAPT therapy to treat patients with symptomatic M2 and M3 occlusions in acute ischemic stroke: initial experience with the Penumbra ACE and 3MAX reperfusion system. J Neurointerv Surg. 2018;10:434–9.

    Article  Google Scholar 

  10. Rethinking Thrombus Removal With the Indigo System: Introducing Lightning Intelligent Aspiration—Endovascular Today.. https://evtoday.com/articles/2020-july/rethinking-thrombus-removal-with-the-indigo-system-introducing-lightning-intelligent-aspiration. Accessed 2 July 2022.

Download references

Acknowledgements

The authors are most grateful to all participants of the survey.

Funding

There was no funding for this study.

Author information

Authors and Affiliations

Authors

Contributions

Nima Kashani, Petra Cimflova: data interpretation, manuscript drafting and critical revision.

Mayank Goyal, Manon Kappelhof, Petra Cimflova: study concept, data acquisition/analysis/interpretation, critical manuscript revision.

Nishita Singh, Rosalie V. McDonough, Mohammed A. Almekhlafi, Michael Chen, Nobuyuki Sakai, Jens Fiehler, Uzair Ahmed, Lissa Peeling, Michael Kelly: curation and interpretation of the data, critical manuscript revision.

Corresponding author

Correspondence to Mayank Goyal.

Ethics declarations

Conflict of interest

M. Goyal is a consultant for Medtronic, Stryker, Microvention, GE Healthcare, Mentice. Johanna Ospel is a consultant for NicoLab. N. Kashani, P. Cimflova, J.M. Ospel, M. Kappelhof, N. Singh, R.V. McDonough, M.A. Almekhlafi, M. Chen, N. Sakai, J. Fiehler, U. Ahmed, L. Peeling and M. Kelly declare that they have no competing interests.

Ethical standards

This study was approved by the Conjoint Health Research Ethics Board of the University of Calgary (REB20-2086). Informed consent: all survey participants provided written informed consent prior to entering survey data.

Supplementary Information

Exemplary cases shown to the participants in the questionnaire are demonstrated in Suppl. Figure 1-3.

Questions included in the questionnaire related to access to endovascular tools.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kashani, N., Cimflova, P., Ospel, J.M. et al. Desired Qualities of Endovascular Tools and Barriers to Treating Medium Vessel Occlusion MeVO. Clin Neuroradiol 33, 155–160 (2023). https://doi.org/10.1007/s00062-022-01196-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00062-022-01196-5

Keywords

Navigation